Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 8974738

[Neuronal plasticity].

I Pascual-Castroviejo
View original source ↗Export metadata ↓

Abstract

The term 'brain plasticity' means the brain capacity to diminish the effects of the lesions through structural functional changes. A great part of the pathological processes of the nervous system affecting the corticospinal and the subcorticospinal tracts, the cerebellar, spinal, visual, language and other systems show neuronal plasticity, spontaneously in some cases and after suitable rehabilitation in others. The clinical manifestations of neuronal plasticity are observed especially after prenatal, neonatal or childhood cerebral damage. During the adulthood, the brain has less capacity of neuronal plasticity, although plastic changes may be found at any age. Apart the clinic, the neuronal plasticity can be studied through electrophysiology, MR, positron emission tomography (PET), transcranial magnetic stimulation (TME), and obviously by histology, this latter especially in experimental studies. In pediatric Neurology, the concept of brain plasticity is frequently used to explain the favourable clinic evolution in a lot of cases with severe brain injury.

Explore related subjects

Age FactorsBrain DiseasesChildDandy-Walker SyndromeElectric StimulationHumansMagnetic Resonance ImagingNeuronal PlasticityTomography, Emission-ComputedTomography, Emission-Computed, Single-PhotonEnglish AbstractJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

I Pascual-Castroviejo. 1996. [Neuronal plasticity].. https://pubmed.ncbi.nlm.nih.gov/8974738/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

Sleep-disordered breathing and periodic limb movements in sleep in older patients with schizophrenia.

BACKGROUND: Since the prevalence of both sleep-disordered breathing (SDB) and periodic limb movements in sleep (PLMS) increase with age, we explored whether older schizophrenia patients would have a high incidence of SDB and PLMS. Correlations between sleep and clinical variables were also examined. METHODS: Fifty-two patients (mean age = 59.6 years, SD = 8.9) had their sleep/wake, respiration, and leg movements recorded using a modified Medilog/Respitrace portable recording system plus oximetry. A battery of clinical, psychosocial, and motor disturbance variables were collected by research center staff. RESULTS: Forty-eight percent of these patients had at least 10 respiratory events per hour of sleep. These patients reported more symptoms of daytime sleepiness than patients with fewer than 10 events per hour. The relatively high prevalence of SDB in this group may contribute to overall sleep disturbances, and does not appear to be a result of high body mass index. Only 14% of the patients had at least five limb movements per hour of sleep, suggesting the prevalence of PLMS is much lower than expected in this age group. The number of leg jerks was inversely related to symptoms of tardive dyskinesia. CONCLUSIONS: The disturbance of sleep in these patients may be due, in part, to SDB, but is unlikely due to PLMS.

Age Factors↗
PubMed1999

Influence of p53 zygosity on select sperm parameters of the mouse.

The influence of p53 gene zygosity on select parameters of mouse sperm was investigated by employing knock-out animal models. The background incidence of sperm shape abnormalities, total sperm count, and DNA double strand breaks were determined in p53 nullizygous (-/-) and heterozygous (+/-) mice and these estimates were compared to the corresponding measures in p53 wild-type (+/+) and the inbred C57Bl6 mouse strains. There were no qualitative differences in the incidence of sperm shape abnormalities and sperm counts regardless of p53 zygosity. However, the number of DNA double strand breaks, as measured by the comet assay, were significantly lower in the p53 knock-out mice. This apparent decrease was interpreted to be the result of a possible change in DNA-protein and/or DNA-DNA cross-linking in the germ cells of the knock-out mice. These data show that there is no evidence of increased incidence of gross alterations in spermatogenesis (no significant loss in sperm production nor any increase in the proportion of abnormal sperm produced) in knock-out mice deficient or absent in p53 protein; however, there appear to be changes at the genomic level where the degree of cross-linking was apparently elevated in DNA from p53 nullizygous and heterozygous mice.

Age Factors↗
PubMed1999

Recombinant TGF-beta1 stimulates bone marrow osteoprogenitor cell activity and bone matrix synthesis in osteopenic, old male mice.

We have previously hypothesized that the osteopenic changes seen in the skeletons of old male BALB/c mice are due to reductions in the availability and/or synthesis of bone TGF-beta which results in fewer, less osteogenic marrow osteoprogenitor cells (CFU-f; OPCs) and lower levels of bone formation. Among other things, this hypothesis would predict that introducing exogenous TGF-beta into old mice (growth factor replacement) should stimulate marrow CFU-f and increase bone formation. In the present study, we have tested this prediction and, indirectly the hypothesis, by injecting human recombinant TGF-beta1, i.p., into both young adult (4 month) and old mice (24 month). The effects of the growth factor on the skeleton were then assessed by measurements of trabecular bone volume, bone formation, fracture healing, and the number, proliferative, apoptotic, and alkaline phosphatase activity of marrow CFU-f/OPCs. Our data show that the introduction of 0.5 or 5.0 ug/day of TGF-beta1 into old mice for 20 days 1) increases trabecular bone volume, bone formation and the mineral apposition rate, 2) augments fracture healing, 3) increases the number and size of CFU-f colonies, and 4) increases proliferation and diminishes apoptosis of CFU-f in primary bone marrow cultures. Importantly, these stimulatory effects of injected growth factor are apparently age-specific, i.e., they are either not seen in young animals or, if seen, are found at much lower levels. While these observations do not exclude other possible mechanisms for the osteopenia of old mice, they provide further support for the hypothesis that, with age, diminished TGF-beta synthesis or availability results in a reduction in the marrow osteoprogenitor pool and bone formation. The findings also demonstrate that the latter changes can be reversed, at least transiently, by introducing exogenous TGF-beta1.

Age Factors↗